Latest Period
n/a
CUSIP: 005111109
Latest Period
n/a
Institutions Reporting
Shares (Excl. Options)
Price
$0.05
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
What is CUSIP 005111109?
CUSIP 005111109 identifies AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Use the next link that matches the question you still need to answer about this security.
Open recent reporting periods for CUSIP 005111109:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Flynn James E | 9.1% | 0% | $233,441 | -$179,058 | 5,492,725 | -43% | James E. Flynn | 27 Jan 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 0 | $0 | -$4 | $0.05 | 0 |
| 2025 Q2 | 2,000 | $4 | $0.00 | 1 | |
| 2025 Q1 | 2,000 | $85 | -$43 | $0.04 | 1 |
| 2024 Q4 | 3,000 | $165 | $0.06 | 1 | |
| 2024 Q3 | 3,000 | $252 | -$286 | $0.08 | 1 |
| 2024 Q2 | 6,400 | $227 | -$1,237,360 | $0.04 | 1 |
| 2024 Q1 | 6,592,463 | $1,238,563 | -$76,859 | $0.19 | 21 |
| 2023 Q4 | 6,995,274 | $1,411,110 | -$885,030 | $0.20 | 27 |
| 2023 Q3 | 8,589,440 | $5,982,496 | -$427,073 | $0.70 | 28 |
| 2023 Q2 | 9,152,813 | $8,125,423 | -$39,586 | $0.89 | 34 |
| 2023 Q1 | 9,230,428 | $6,957,352 | -$337,566 | $0.75 | 37 |
| 2022 Q4 | 9,249,623 | $10,637,045 | -$1,090,548 | $1.15 | 35 |
| 2022 Q3 | 10,327,199 | $9,087,000 | -$958,274 | $0.88 | 30 |
| 2022 Q2 | 11,180,047 | $12,516,000 | -$5,242,416 | $1.12 | 41 |
| 2022 Q1 | 15,930,046 | $22,142,780 | -$3,508,681 | $1.39 | 59 |
| 2021 Q4 | 17,800,805 | $60,690,000 | -$44,289,931 | $3.41 | 67 |
| 2021 Q3 | 20,249,026 | $179,069,000 | -$37,260,622 | $8.84 | 66 |
| 2021 Q2 | 23,181,575 | $393,897,000 | +$10,530,619 | $16.98 | 64 |
| 2021 Q1 | 22,813,007 | $304,806,000 | -$12,262,255 | $13.37 | 65 |
| 2020 Q4 | 20,785,062 | $598,581,348 | +$43,795,744 | $28.81 | 63 |
| 2020 Q3 | 19,216,927 | $572,658,314 | +$572,658,314 | $29.80 | 68 |